Speakers

Thierry Schlama has 24 years experience in chemical processes and innovative technologies development. He joined Novartis in 2006 where he held different roles within TRD-CHAD. Recipient of the Novartis Global Innovation award (VIVA) in 2017, Thierry has been instrumental in building strategic partnerships, creating innovation platforms, and leading biocatalysis implementation within CHAD organization from early to full scale manufacturing. Author of several publications, patent and book chapters, Thierry holds a PhD in Organic Chemistry from the University of Strasbourg and he’s passionate of changing the way we do organic chemistry using the power of enzymes. He’s the Director of the Biocatalysis in Chemical Development and Global Platform Leader of the Biocatalysis technology.

Presentation Title: Achieving Strong Innovation in Pharmaceutical Development through Strategic Partnering in the Field of Biocatalysis

Abstract: An overview, at Novartis Pharma, of Biocatalysis Projects co-developed with Technology providing companies will be given through early phase projects up to full scale manufacturing. Consideration on enzyme evolution will be given.

View company profile